A Study to Investigate the Exposure of Budesonide, Glycopyrronium, and Formoterol (BGF) Delivered by Hydrofluoroolefin (HFO) Propellant Metered Dose Inhaler (MDI) Compared to a Hydrofluoroalkane (HFA) Propellant MDI in Healthy Adults

NCT06723756 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: Treatment A: BGF MDI HFO
DRUG: Treatment B: BGF MDI HFA

Sponsor

AstraZeneca

Collaborators

[object Object]